BioAmber
BIOA • XNYS
BioAmber is a publicly traded company trading on XNYS, led by CEO Kristen Fortney, with a market cap of $716.7M.
CEOKristen Fortney
Market Cap$716.7M
Next Earnings
Upcoming earnings announcement for BioAmber
Date
Tuesday, May 5, 2026 (in a month)
Timing
Before Market Open (2:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.66
Revenue Estimate
$1.1M
Earnings History
Past 12 earnings reports for BioAmber
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 24, 2026 | Q4 2025 | -$0.72Est: -$0.73 | +1.4% | $3.1MEst: $1.9M | +60.7% | — |
| Nov 6, 2025 | Q3 2025 | -$0.56Est: -$0.58 | +3.4% | $2.1MEst: $777.5K | +164.2% | — |
| Aug 6, 2025 | Q2 2025 | -$0.60Est: -$0.45 | -33.3% | $2.4MEst: $580.0K | +315.9% | — |
| May 6, 2025 | Q1 2025 | -$0.36Est: -$0.53 | +32.1% | $1.5M | — | — |
| Mar 20, 2025 | Q4 2024 | -$0.59Est: -$0.83 | +28.9% | - | — | — |
| Nov 7, 2024 | Q3 2024 | -$6.70 | — | - | — | — |
| Mar 30, 2018 | Q4 2017 | -$1.61 | — | $5.4MEst: $3.3M | +63.5% | — |
| Nov 7, 2017 | Q3 2017 | -$0.21 | — | $3.3MEst: $6.8M | -51.1% | — |
| Aug 3, 2017 | Q2 2017 | -$0.20Est: -$0.13 | -53.8% | $4.1MEst: $4.4M | -7.0% | — |
| May 9, 2017 | Q1 2017 | -$0.31Est: -$0.13 | -138.5% | $2.1MEst: $4.0M | -47.2% | — |
| Mar 16, 2017 | Q4 2016 | -$0.27Est: -$0.18 | -50.0% | $631.0KEst: $3.8M | -83.3% | — |
| Nov 3, 2016 | Q3 2016 | -$0.26Est: -$0.22 | -18.2% | $3.7MEst: $3.9M | -4.9% | — |